Compare IDEXX Laboratories, Inc. (IDXX) vs Suncor Energy Inc. (SU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Suncor Energy Inc. — how do they compare? IDEXX Laboratories, Inc. trades at $569.65 (market cap $46.22B), while Suncor Energy Inc. trades at $63.28 (market cap $74.07B). The key difference: Suncor Energy Inc. is the larger of the two by market cap, and Suncor Energy Inc. pays a 2.7% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| IDXX | SU | |
|---|---|---|
Market Cap | $46.22B | $74.07B |
Sector | Health | Energy |
52-Week High | $766.68 | $69.73 |
52-Week Low | $526.44 | $38.17 |
Enterprise Value | $47.12B | $80.75B |
Dividend Yield | — | 2.7% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $570.58, down 4.23% over 24 hours, with a bullish technical signal and strong fundamentals. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $4.27 surpassing the $3.94 expectation. Revenue growth remains robust, supported by a 74.21% ROE and expanding diagnostic offerings. Recent news highlights product expansion, including a dual-species cardiac test, reinforcing its market leadership in veterinary diagnostics.
The outlook is positive, driven by durable competitive advantages and international growth potential. However, elevated valuation multiples and competitive pressures pose risks. Analyst consensus is bullish with a $683.33 price target, suggesting significant upside from current levels, though investors should monitor execution on guidance and macroeconomic headwinds.
Suncor Energy (SU) trades at $63.82, up 1.74% on the day, with a neutral technical signal. The stock shows strong fundamentals, including a P/E of 11.79, a net income margin of 14.7%, and a robust ROE of 19.25%. Recent Q2 2026 earnings beat estimates, and the company has declared consistent dividends. Leadership transition plans are in place, with Peter Zebedee set to become CEO in 2027.
The outlook is positive, supported by strong cash flow, shareholder returns, and favorable analyst sentiment. Key risks include commodity price volatility and operational challenges. With 74% of analysts rating it a buy and no sell ratings, the stock presents a compelling opportunity for value and income investors, though macroeconomic factors remain a watchpoint.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Suncor Energy Inc.
Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.
Read more on SU →
